Yaacov David-Ben

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Guiyang, 550014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Journal: Biochemical pharmacology

Published: April 21, 2026

The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.

The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.

Journal: Chemico-biological interactions

Published: December 28, 2025

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Journal: Cell reports

Published: November 05, 2025

TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.

TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.

Journal: British journal of cancer

Published: September 19, 2025

Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.

Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.

Journal: Fitoterapia

Published: September 01, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.

L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.

Journal: Frontiers in pharmacology

Published: January 21, 2025

Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.

Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.

Journal: Medical oncology (Northwood, London, England)

Published: January 16, 2025

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Journal: Cancers

Published: January 13, 2025

Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice.

Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice.

Journal: Frontiers in pharmacology

Published: December 09, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026